Works by Shan, Renfeng

Results: 12

Comprehensive Analysis of circRNA, lncRNA, miRNA and mRNA Expression Profiles and Their Competing Endogenous RNA Networks in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Published in:

Molecular Biotechnology, 2025, v. 67, n. 1, p. 329, doi. 10.1007/s12033-024-01056-2

By:

Yan, Shaoying;
Fu, Peng;
Li, Huiming;
Huang, Zikun;
Shan, Renfeng;
Gong, Binbin

Publication type:

Article

Prognostic Value of Alpha-Fetoprotein in Unresectable Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab.

Published in:

Journal of Hepatocellular Carcinoma, 2024, v. 11, p. 1251, doi. 10.2147/JHC.S460922

By:

Xiao, Yongqiang;
Chen, Wanqing;
Deng, Wei;
Zhu, Guoqing;
Xie, Jin;
Luo, Laihui;
Lin, Liucong;
Tao, Jiahao;
Hu, Zhigao;
Shan, Renfeng

Publication type:

Article

Rare benign liver tumors that require differentiation from hepatocellular carcinoma: focus on diagnosis and treatment.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 2843, doi. 10.1007/s00432-022-04169-w

By:

Luo, Laihui;
Wang, Tao;
Cheng, Mengting;
Ge, Xian;
Song, Shengjiang;
Zhu, Guoqing;
Xiao, Yongqiang;
Deng, Wei;
Xie, Jin;
Shan, Renfeng

Publication type:

Article

The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14185-x

By:

Deng, Wei;
Xie, Jin;
Wang, Tao;
Luo, Laihui;
Zhu, Guoqing;
Xiao, Yongqiang;
Tao, Jiahao;
Lin, Liucong;
Ge, Xian;
Wen, Wu;
Wang, Minglong;
Yu, Bin;
Liu, Yu;
Luo, Rongguang;
Wan, Renhua;
Hu, Zhigao;
Shan, Renfeng

Publication type:

Article

Identification of a Novel Survival-Related circRNA–miRNA–mRNA Regulatory Network Related to Immune Infiltration in Liver Hepatocellular Carcinoma.

Published in:

Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.800537

By:

Gan, Yu;
Fang, Weidan;
Zeng, Yan;
Wang, Peijun;
Shan, Renfeng;
Zhang, Ling

Publication type:

Article

Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus‐related hepatocellular carcinoma.

Published in:

International Journal of Cancer, 2022, v. 151, n. 10, p. 1824, doi. 10.1002/ijc.34201

By:

Fu, Peng;
Gong, Binbin;
Li, Huiming;
Luo, Qing;
Huang, Zikun;
Shan, Renfeng;
Li, Junming;
Yan, Shaoying

Publication type:

Article

Targeting Notch4 in Cancer: Molecular Mechanisms and Therapeutic Perspectives.

Published in:

Cancer Management & Research, 2021, v. 13, p. 7033, doi. 10.2147/CMAR.S315511

By:

Xiu, Mengxi;
Zeng, Xiaohong;
Shan, Renfeng;
Wen, Wu;
Li, Jianfeng;
Wan, Renhua

Publication type:

Article

Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma.

Published in:

BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12355-x

By:

Xiao, Yongqiang;
Deng, Wei;
Luo, Laihui;
Zhu, Guoqing;
Xie, Jin;
Liu, Yu;
Wan, Renhua;
Wen, Wu;
Hu, Zhigao;
Shan, Renfeng

Publication type:

Article

AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 9, p. 1814, doi. 10.1002/mc.23775

By:

Zhu, Guoqing;
Luo, Laihui;
He, Yongzhu;
Xiao, Yongqiang;
Cai, Ziwei;
Tong, Weilai;
Deng, Wei;
Xie, Jin;
Zhong, Yanxin;
Hu, Zhigao;
Shan, Renfeng

Publication type:

Article

The clinical significance and prognostic value of Xenopus kinesin‐like protein 2 expressions in human tumors: A systematic review and meta‐analysis.

Published in:

Journal of Cellular Physiology, 2019, v. 234, n. 9, p. 14991, doi. 10.1002/jcp.28343

By:

Yang, Weina;
Wan, Haiting;
Shan, Renfeng;
Wen, Wu;
Li, Jianfeng;
Luo, Daya;
Wan, Ren‐Hua

Publication type:

Article

Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: A tertiary medical center experience.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1004652

By:

Laihui Luo;
Yongqiang Xiao;
Guoqing Zhu;
Aihong Huang;
Shengjiang Song;
Tao Wang;
Xian Ge;
Jin Xie;
Wei Deng;
Zhigao Hu;
Wu Wen;
Haoran Mei;
Renhua Wan;
Renfeng Shan

Publication type:

Article

Development and validation of nomograms to evaluate the survival outcome of HCC patients undergoing selective postoperative adjuvant TACE.

Published in:

La Radiologia Medica, 2024, v. 129, n. 4, p. 653, doi. 10.1007/s11547-024-01792-0

By:

He, Yongzhu;
Qian, Junlin;
Zhu, Guoqing;
Wu, Zhao;
Cui, Lifeng;
Tu, Shuju;
Luo, Laihui;
Shan, Renfeng;
Liu, Liping;
Shen, Wei;
Li, Yong;
He, Kun

Publication type:

Article